Cargando…
Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells
BACKGROUND: To specifically deliver paclitaxel (PTX) to retinoblastoma (RB) cells, the anionic surface-charged poly(lactic-co-glycolic acid) (PLGA) NPs loaded with paclitaxel were conjugated with epithelial cell adhesion molecule (EpCAM) antibody for enhancing site-specific intracellular delivery of...
Autores principales: | Mitra, Moutushy, Misra, Ranjita, Harilal, Anju, Sahoo, Sanjeeb K, Krishnakumar, Subramanian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3209422/ https://www.ncbi.nlm.nih.gov/pubmed/22065926 |
Ejemplares similares
-
EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy
por: Mitra, Moutushy, et al.
Publicado: (2012) -
Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
por: Mitra, Moutushy, et al.
Publicado: (2010) -
Erratum to: Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
por: Mitra, Moutushy, et al.
Publicado: (2011) -
Withdrawal: Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells
por: The Editors of Molecular Vision,
Publicado: (2013) -
Genome-wide changes accompanying the knockdown of Ep-CAM in retinoblastoma
por: Mitra, Moutushy, et al.
Publicado: (2010)